EATING foods with key nutrients could lower your risk of 14 types of cancer, scientists say. A diet rich in so-called “healthy fats” have previously been linked to improved brain and ...

Another study, published in the International Journal of Cancer, found that consumption of omega-3 and omega-6 fatty acids could lower the risk of 19 types of cancer. Omega-6s work similarly in the ...

I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I ...

A fatty liver can lead to various health issues, including liver damage, cancer, stroke, diabetes, kidney disease, and ...

A fatty liver can cause a number of health problems such as liver damage, cancer, stroke, diabetes, kidney disease and ...

Frying your eggs at high temperatures may cause cholesterol to release harmful chemicals called oxysterols, which have been linked to heart disease and several forms of cancer.

Meanwhile, genes and proteins involved bile acid signaling pathway were analyzed both in the liver and ileum tissues. Conclusion: Sex-specific differences in the structure of the gut microbiota are ...

Gastroesophageal reflux disease (GERD) is a condition in which stomach acid (or other things such as bile or food) regularly travels back up through the esophagus, usually causing a sour taste and ...

Bile duct cancer, also known as cholangiocarcinoma, refers to a group of cancers that develop in the bile ducts. Bile duct cancer is rare in the United States, with about 8,000 people diagnosed ...

HER2-targeted therapies, originally developed for breast cancer, may also benefit patients with rare bile duct cancer and HER2-mutated breast cancer. Drugs aimed at HER2-positive breast cancer may ...

Researchers at the National Cancer Centre Hospital in Kashiwa, Japan, explored the use of the treatment for other cancers, including that of the bile ducts. Bile duct cancer, also known as ...

Drugs that target advanced breast cancer could help patients with a rare cancer that affects parts of the digestive system, a trial has found. Tucatinib and trastuzumab work by blocking a protein ...